Q4 2024 Paysign Inc Earnings Call Transcript
Key Points
- PaySign Inc (PAYS) reported a 23.5% increase in revenue for 2024, reaching $58.4 million.
- The patient affordability business segment grew significantly, with a 212% increase in annual revenue, reaching $12.7 million.
- Adjusted EBITDA increased by 43.3% to $9.6 million, with margins improving by 230 basis points to 16.5%.
- The company successfully added 33 net programs in the patient affordability segment, representing a 77% increase over the previous year.
- PaySign Inc (PAYS) announced the acquisition of Gamma Innovation LLC, enhancing its capabilities in plasma donor and pharmaceutical patient engagement.
- The plasma donor compensation business experienced a 6.2% decline in fourth-quarter revenue due to an oversupply of source plasma.
- Gross dollars loaded to cards decreased by 6.4%, and the average revenue per plasma center decreased by 9.5%.
- Operating expenses increased by 34.2% to $8.7 million, driven by investments in IT and employees.
- Net income for the fourth quarter was $1.4 million, a decrease from $5.6 million in the same period last year.
- The company expects continued challenges in the plasma business due to excess inventory supplies, impacting revenue for the remainder of 2025.
Good afternoon. My name is Kevin, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the pay signing fourth quarter and full year 2024 earnings conference call. After the speaker's remarks, there'll be a question-and-answer session.
(Operator Instructions)
As a reminder, this conference call is being recorded.
The comments on today's call regarding pay signs financial results will be on a GAAP basis unless otherwise noted. Paysign's earnings release was disseminated to the SEC earlier today and can be found on the investor relations section of our website Paysign.com, which includes reconciliations of non-gap measures to GAAP reported amounts.
Additionally, as set forth in more detail in our earnings release, I'd like to remind everyone that today's call will include forward-looking statements regarding Paysign's future performance. Actual performance could differ materially from these forward-looking statements. Information about the factors that could affect future performance is summarized at the end of Paysign's earnings
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
